Dopa-responsive dystonic camptocormia.
Micheli
Federico
F
Pardal
Manuel M Fernandez
MM
D000328:Adult; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use; D004421:Dystonia / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007738:Kyphosis / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000294:innervation / Q000503:physiopathology; D012600:Scoliosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D013131:Spine / Q000503:physiopathology; D016896:Treatment Outcome
D015259:Dopamine Agents; D004295:Dihydroxyphenylalanine